{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:37:46Z","timestamp":1791135466980,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.biocel.2009.08.002","type":"journal-article","created":{"date-parts":[[2009,8,9]],"date-time":"2009-08-09T04:20:44Z","timestamp":1249791644000},"page":"2351-2355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Cardiac hypertrophy: Targeting Raf\/MEK\/ERK1\/2-signaling"],"prefix":"10.1016","volume":"41","author":[{"given":"Kristina","family":"Lorenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim P.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2009.08.002_bib1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.biocel.2009.08.002_bib2","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.biocel.2009.08.002_bib3","doi-asserted-by":"crossref","first-page":"H284","DOI":"10.1152\/ajpheart.00128.2007","article-title":"Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay","volume":"293","author":"Depold","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.biocel.2009.08.002_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/hc0102.101365","article-title":"Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress","volume":"105","author":"Esposito","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2009.08.002_bib5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2009.08.002_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.devcel.2009.01.021","article-title":"A new Gq-initiated MAPK-signaling pathway in the heart","volume":"16","author":"Gutkind","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.biocel.2009.08.002_bib7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.0000138190.50127.6A","article-title":"Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload","volume":"110","author":"Harris","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2009.08.002_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.biocel.2009.08.002_bib9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biocel.2009.08.002_bib10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1242\/jcs.115.8.1575","article-title":"Extracellular signal regulated kinase (ERK)\/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases","volume":"115","author":"Hindley","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.biocel.2009.08.002_bib11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/CIRCULATIONAHA.107.728865","article-title":"Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase\/mitogen-activated protein kinase and RhoA signaling pathways","volume":"117","author":"Kontaridis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2009.08.002_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.1893","article-title":"A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy","volume":"15","author":"Lorenz","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.biocel.2009.08.002_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/15406580360545143","article-title":"Signaling in time and space: G protein-coupled receptors and mitogen-activated protein kinases","volume":"1","author":"Luttrell","year":"2003","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.biocel.2009.08.002_bib14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","article-title":"Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril","volume":"104","author":"Mathew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2009.08.002_bib15","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/emboj\/20.8.1952","article-title":"Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene","volume":"20","author":"Mikula","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.biocel.2009.08.002_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1152\/physiolgenomics.00224.2005","article-title":"Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation","volume":"25","author":"Mitchell","year":"2006","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.biocel.2009.08.002_bib17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardiores.2005.06.020","article-title":"Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition","volume":"68","author":"Munzel","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biocel.2009.08.002_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/CS20070430","article-title":"MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets","volume":"115","author":"Muslin","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.biocel.2009.08.002_bib19","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI30756","article-title":"Mediating ERK 1\/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome","volume":"117","author":"Nakamura","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biocel.2009.08.002_bib20","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1038\/sj.onc.1210412","article-title":"Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases","volume":"26","author":"Owens","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2009.08.002_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.biocel.2009.08.002_bib22","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2009.08.002_bib23","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1038\/sj.onc.1210392","article-title":"Differential regulation and properties of MAPKs","volume":"26","author":"Raman","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2009.08.002_bib24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.HYP.0000062881.36813.7A","article-title":"Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats","volume":"41","author":"Sanada","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.biocel.2009.08.002_bib25","first-page":"14525","volume":"103","author":"Schmitt","year":"2006","journal-title":"Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function. Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2009.08.002_bib26","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1172\/JCI34472","article-title":"An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice","volume":"118","author":"Sheikh","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biocel.2009.08.002_bib27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0960-9822(99)80426-6","article-title":"Binding of Gbetagamma subunits to cRaf1 downregulates G-protein-coupled receptor signalling","volume":"9","author":"Slupsky","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.biocel.2009.08.002_bib28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","article-title":"Mitogen-activated protein kinases in heart development and diseases","volume":"116","author":"Wang","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2009.08.002_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1172\/JCI200420317","article-title":"Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis","volume":"114","author":"Yamaguchi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biocel.2009.08.002_bib30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.RES.86.6.692","article-title":"Inhibition of extracellular signal-regulated kinase enhances ischemia\/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart","volume":"86","author":"Yue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.biocel.2009.08.002_bib31","doi-asserted-by":"crossref","first-page":"H424","DOI":"10.1152\/ajpheart.00110.2003","article-title":"Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart","volume":"286","author":"Zheng","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.biocel.2009.08.002_bib32","doi-asserted-by":"crossref","first-page":"33181","DOI":"10.1074\/jbc.M705133200","article-title":"Glycogen synthase kinase-3\u03b1 reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases","volume":"282","author":"Zhai","year":"2007","journal-title":"J Biol Chem"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272509002258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272509002258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:36:40Z","timestamp":1761201400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272509002258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1357272509002258"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2009.08.002","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac hypertrophy: Targeting Raf\/MEK\/ERK1\/2-signaling","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2009.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}